Leukemia is a cancer of the blood or blood cells. It is classified by two factors:
Cells affected by leukemia are made in your bone marrow. Bone marrow is the spongy area in the center of bones. Larger bones have more bone marrow. This means they make more cells. Larger bones are the femur (top part of the leg or thigh), the hip bones, and parts of the rib cage. Some cells in the bone marrow are still developing and are not yet mature. These cells are called “blasts.” Once the cell has matured, it moves out of the bone marrow and into the bloodstream. The body knows when more cells are needed and makes them.
In leukemia, a certain type of blood cell does not work as it should, and the body makes too many of these cells. When looked at under a microscope, these cells look different than healthy cells and do not work the way they should. The body keeps making these non-working cells, leaving little space for healthy cells. This imbalance of healthy and unhealthy cells causes leukemia and its symptoms:
Most cancers are staged based on where the cancer started, how big the tumor is, and where it has spread (metastasized). Leukemia is a cancer of the blood and is not staged like most cancers. Most leukemias are classified into types instead of stages. When deciding treatment for leukemia, your provider will look at:
There are a few subtypes of leukemia, based on which cells are affected in the bone marrow. Some of them are staged and others are not.
ALL is classified by the World Health Organization (WHO) system based on the type of cells it starts in, B-cell ALL (beginning in immature B-cells) or T-cell ALL (beginning in immature T-cells). It is further classified depending on the changes seen in the genes and chromosomes of the cells. Talk with your care team about the specific classification of your diagnosis.
AML may also be called acute myelocytic leukemia, acute granulocytic leukemia, or acute non-lymphocytic leukemia. The French-American-British (FAB) classification and the newer World Health Organization (WHO) system are used to classify AML. To classify AML, the World Health Organization (WHO) system considers:
You can talk with your care team about the specific classification of your leukemia.
There are two different staging systems for CLL:
Rai Staging System- Based on results of blood tests (especially the number of white blood cells) and physical exam.
In each stage, there is lymphocytosis. Lymphocytosis is a higher-than-normal white blood cell (WBC) count. The extra WBCs are found in the blood and bone marrow.
Each stage is also put into a risk group that helps decide which treatments are best:
Binet Staging System- Based on the number of affected lymphoid tissue groups and if you have anemia or thrombocytopenia.
The Binet system looks at lymphoid tissue, anemia (not having enough healthy red blood cells), and thrombocytopenia (low platelets). Lymphoid tissue groups include the neck lymph nodes, groin lymph nodes, underarm lymph nodes, spleen, and liver.
CML is broken down into three phases. The phases are based mainly on the number of immature white blood cells (blasts) in the blood or bone marrow. There is no set system for CML, but common classifications (by the World Health Organization) are:
Treatment for leukemia depends on many factors, such as your age and overall health, the type of leukemia you have, and whether it has spread to other parts of your body, including the central nervous system (CNS). Your treatment may include some or all of the following:
Talk with your care team about the subtype of leukemia you have, which stage or phase it is, and what the best treatment options are for you. You can read more about each leukemia subtype at OncoLink.org.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania